AI News NQ Analysis

WAKANSE (1783) March 2026 Revenue: 70 Million Yen (Year-on-Year +0.1%)

NQ Score 4/100
N1 Content Completeness 5

AI Summary (NQ-processed)

WAKANSE announced its revenue for March 2026, reaching 69.939 million yen (approximately 0.70 hundred million yen), a slight increase of 0.1% compared to the same period last year. The company operates in the biotechnology and healthcare industry.

AI Analysis

Frequently Asked Questions

Q: What was WAKANSE's revenue for March 2026?
A: WAKANSE's monthly revenue for March 2026 was approximately 70 million yen (69.939 million yen).
Q: How did the revenue compare to the same month last year?
A: It increased by 0.1% compared to the same month last year.
Q: What kind of business does WAKANSE operate?
A: WAKANSE operates in the biotechnology and healthcare industry, developing and selling pharmaceuticals and medical devices.